Presentation is loading. Please wait.

Presentation is loading. Please wait.

Candida albicans Figure 1. Skin Smear Candida albicans

Similar presentations

Presentation on theme: "Candida albicans Figure 1. Skin Smear Candida albicans"— Presentation transcript:

1 Candida albicans Figure 1. Skin Smear Candida albicans

2 Contents 1.Introduction to Mycology 2.Biological Profile 3.Disease capabilities 4.Pathogenesis 5.Detection 6.Drug therapy 7.Research

3 The Situation Frequency - most common fungal pathogen worldwide - 4th leading causes of nosocomial infections, 40% mortality - significant mortality and morbidity in low birth-weight infants - affects 75% women, 45% experience recurrence A > 10 million visits/year - classified as a STD by CDC Immunocompromised - cancer and HIV-AIDs patients C - most commonly manifested in patients with leukemia or HIV-AIDs infections. Oral candidiasis is often a clue to acute primary infection C Public Concerns - increasing resistance to drug therapies due to antibiotics and antifungals

4 Mycology Basics Kingdom: Fungi More than 10 million species, but only ~400 human disease (*) Sexual Groups Ascomycota* Basidiomycota* Zygomycota* Chytridia Fungi Imperfecti* Very few species are in a commensal relationship with humans - includes Candida albicans and Malasezia furfur Diseases caused by fungi are usually accidental Endogenous and Exogenous Sources Increasing problem due to antibacterial & immunosuppressive agents Molecular mechanisms of pathogenesis not well-defined

5 The 5 main groups Figure 1. Classification of Fungi. Fungi are classified based on their ability to reproduce sexually, asexually, by a combination of both. The different reproductive structures places them in the appropriate category. (Baron, 1996)

6 Figure 1. Penicillium chrysogenum Fungal Characteristics Plant-like lacking chlorophyll Cell wall chitinous matrix Free-living saprobes and heterotrophs needs Carbon source and Nitrogen source Yeasts or Molds or both Success of an infection Accidental Overcoming host barriers Presiding in host with immunological defects

7 Figure 1. Typical YeastFigure 2. Typical mould Yeast Characteristics solitary, unicellular reproduction via budding rounded shape moist & mucoid colonies Mould Characteristics filamentous hyphae hyphal formation tips may be rounded (conidia/spores)

8 Yeast Bud Formation Figure 1. Stages of bud growth and yeast cell cycle (Baron et. Al., 1996)

9 Hyphal Formation Figure 1. Polarized hyphal formation (Baron et. Al., 1996)

10 Biology of Candida albicans Commensal Pathogen A thin-walled dimorphic fungus Morphogenesis Unicellular yeast (harmeless) Filamentous (pathogenic) Principal Cell Wall Polymers Gluccan Mannan Strict aerobe, favors moist surfaces Commensally found in gut, genitals, and lungs Body Temp 37º C, neutral pH Figure 1. Yeast in Oral Scraping A sample of an oral scraping contains yeast cells and pseudohyphae ( Rapid Multiplication & Spread

11 Diseases by C. albicans Thrush Esophagitis Cutaneous Candidiasis Genital Yeast Infections Deep Candidiasis

12 Figure 1. Angular chelitis ( Figure 2. Oral Thrush, atrophic ( Figure 3. Oral Thrush, pseudomembranous ( Oropharyngeal Thrush * Pseudomembranous * Atrophic * Angular chelitis Symptoms Risk Factors HIV Treatment: topical antifungals

13 Genital Yeast Candidiasis Symptoms Risk Factors - disruption of normal microbiota Treatment - direct genital administration - tablets, suppositories, creams Figure 1. Vaginal Yeast Culture ( Figure 2. Plasma cell balanitis. A band-like infiltrate of plasma cells is in the dermis of the male penis. (

14 Deep Candidiasis Figure 1. Four forms of invasive candidiasis (

15 Pathogenesis Host Recognition Adhesins Enzymes Hydrolases: Phosphoplipases, Lipases, Proteinases Morphogenesis Yeast form to Filamentous hyphae/pseudohyphae Phenotypic Switching

16 Figure 1. skin equivalent before infection Figure 2. Infection with pathogenic clinical isolate of C. albicans. After 48 h the yeast penetrates the skin equivalent and destroys the tissue Figure 3. Infection with non-pathogenic C. albicans. This strain is not able to penetrate into the tissue and thus behaves as avirulent as shown in the mouse model of systemic infection. Virulence assay of different C. albicans strains using the skin equivalent (AST 2000) (Fraunhofer, 2002)

17 MORPHOGENESIS Figure 2. Morphogenic forms of Candida albicans Figure 1. Morphogenesis. Morphogenesis in C. albicans is a pivotal virulence factor that allows rapid multiplication and subsequent dissemination in host tissue. (

18 Tools for Detection & Diagnosis PCR Based Molecular Techniques targets SAPs Advantages Disadvantages Future Non-PCR Based Fluorescent in situ hybridization Old Methods Restriction Enzyme Analysis Current methods Culture and Serology Fig. 1. Throat Swab (

19 Current Drug Therapies FDA approved antifungal drugs Amphotericin B (Fungizone) Clotrimazole (Mycelex) Fluconazole (Diflucan) Itraconazole (Sporanox) Ketoconazole (Nizoral) Nystatin (Mycostatin) Major Drug Categories Polyenes Problems: Azoles Problems: Enhanced drug efflux Catalase activity, ergosterol production Fig. 1. Fungizone (

20 Research Biotechnological methods for rapid identification and detection of Candida strains New antifungal agents Molecular pathogenesis Emerging opportunistic strains Public Health Measures in limiting nosocomial-related infections

21 References 23. Burnie J. & R. Matthews. 2003. The role of antibodies against hsp90 in the treatment of fungal infections Drug News Perspect 16(4): 205-210.

Download ppt "Candida albicans Figure 1. Skin Smear Candida albicans"

Similar presentations

Ads by Google